Skip to main content
Clinical Trials/JPRN-UMIN000014311
JPRN-UMIN000014311
Not yet recruiting
未知

Examination of the clinical remission and functional remission in Infliximab using the increase-in-quantity protocol to TNF-alpha inhibitory drug resistance rheumatoid arthritis - Examination of the clinical remission and functional remission in Infliximab using an increase-in-quantity protocol

Institute of Health Biosciences, The University of Tokushima Graduate School0 sites10 target enrollmentJune 24, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
rheumatoid arthritis
Sponsor
Institute of Health Biosciences, The University of Tokushima Graduate School
Enrollment
10
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 24, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institute of Health Biosciences, The University of Tokushima Graduate School

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)The patient who cannot use MTX 2\)The patient who cannot use Infliximab 3\)THe patient who ever used Infliximab

Outcomes

Primary Outcomes

Not specified

Similar Trials